- Home
- ASTL vs SAGE Comparison
ASTL vs SAGE Comparison
Compare ASTL & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- SAGE
- Stock Information
- Founded
- ASTL 1902
- SAGE 2010
- Country
- ASTL Canada
- SAGE United States
- Employees
- ASTL 2818
- SAGE N/A
- Industry
- ASTL Steel/Iron Ore
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- ASTL Industrials
- SAGE Health Care
- Exchange
- ASTL Nasdaq
- SAGE Nasdaq
- Market Cap
- ASTL 733.5M
- SAGE 571.1M
- IPO Year
- ASTL N/A
- SAGE 2014
- Fundamental
- Price
- ASTL $6.97
- SAGE $9.27
- Analyst Decision
- ASTL
- SAGE Hold
- Analyst Count
- ASTL 0
- SAGE 18
- Target Price
- ASTL N/A
- SAGE $9.89
- AVG Volume (30 Days)
- ASTL 1.0M
- SAGE 3.2M
- Earning Date
- ASTL 07-22-2025
- SAGE 07-30-2025
- Dividend Yield
- ASTL 2.86%
- SAGE N/A
- EPS Growth
- ASTL N/A
- SAGE N/A
- EPS
- ASTL N/A
- SAGE N/A
- Revenue
- ASTL $1,635,857,227.00
- SAGE $47,404,000.00
- Revenue This Year
- ASTL $0.95
- SAGE $102.21
- Revenue Next Year
- ASTL $21.63
- SAGE $43.01
- P/E Ratio
- ASTL N/A
- SAGE N/A
- Revenue Growth
- ASTL N/A
- SAGE N/A
- 52 Week Low
- ASTL $4.17
- SAGE $4.62
- 52 Week High
- ASTL $12.14
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- ASTL 59.49
- SAGE 73.46
- Support Level
- ASTL $6.88
- SAGE $9.10
- Resistance Level
- ASTL $7.14
- SAGE $9.22
- Average True Range (ATR)
- ASTL 0.26
- SAGE 0.12
- MACD
- ASTL -0.03
- SAGE -0.05
- Stochastic Oscillator
- ASTL 59.06
- SAGE 71.88
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.